Bronnen:
- von Groote-Bidlingmaier F, Patientia R, Sanchez E, et al. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre randomised, double-blind, placebo-controlled, parallel group phase 3 trial. Lancet Respir Med. 2019 Jan 7.